This compound is a protected phosphoramidite monomer used as a building block in oligonucleotide synthesis. It features a (S)-GNA backbone with a benzoyl-protected cytosine nucleobase and acid-labile dimethoxytrityl (DMT) protecting group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing (S)-GNA-C(Bz)-phosphoramidite?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N4-Ac-C-(S)-GNA phosphoramidite
pharmaceutical intermediate
(S)-GNA-G(iBu) phosphoramidite
pharmaceutical intermediate
(S)-GNA-A(Bz)-phosphoramidite
pharmaceutical intermediate
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-5-methyluridine
pharmaceutical intermediate
Guanosine, 3′-O-(2-methoxyethyl)-
pharmaceutical intermediate
1-[3-(Benzoyloxy)propyl]-2,3-dihydro-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indole-7-carbonitrile ethanedioate
pharmaceutical intermediate
[[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]methyl]triphenylphosphonium bromide
pharmaceutical intermediate
6-Bromo-4-indazolecarboxylic acid methyl ester
pharmaceutical intermediate
N-[1-[(2S)-3-[bis(4-methoxyphenyl)-phenylmethoxy]-2-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxypropyl]-2-oxopyrimidin-4-yl]benzamide
IQSXGILXOHYNMA-CIMWKYAKSA-N
CC(C)N(C(C)C)P(OCCC#N)O[C@@H](CN1C=CC(=NC1=O)NC(=O)C2=CC=CC=C2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC
Sourcing (S)-GNA-C(Bz)-phosphoramidite?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.